Go to content
Kiadis Pharma N.V.

Kiadis Pharma N.V.

Below you will find information from the register publication of inside information. The information has been provided by the organisation.

Registration date 06 may 2020 - 08:00
Statutory name Kiadis Pharma N.V.
Title Kiadis Pharma announces U.S. FDA approval to start NK-REALM Phase 2 clinical trial for natural killer (NK) cell therapy produced with PM21
Previous result
Next result

Related downloads

202005060000000007_Kiadis Pharma announces U.S. FDA approval to start NK-REALM Phase 2 clinical trial for natural killer (NK) cell therapy produced with PM21.pdf (opens in a new window)
202005060000000007_Kiadis Pharma kondigt goedkeuring van Amerikaanse FDA aan voor start van NK.pdf (opens in a new window)

Date last update: 10 July 2025